354 Participants Needed

Virtual Care for Acute Kidney Injury

(UPTAKE-VC Trial)

Recruiting at 1 trial location
D
Overseen ByDirector
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Calgary
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 1 JurisdictionThis treatment is already approved in other countries

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your healthcare provider.

What data supports the effectiveness of the treatment Virtual Care, Telemedicine, Remote Monitoring, Virtual Home Hospital for Acute Kidney Injury?

Research shows that remote patient management, a form of virtual care, improves outcomes for patients on home-based dialysis by allowing early problem detection and reducing hospital visits. Additionally, telemedicine has been effective in managing critically ill patients in rural areas, maintaining healthcare standards without the need for long-distance travel.12345

Is virtual care safe for patients with kidney conditions?

Virtual care, including telemedicine and remote monitoring, has been used safely for patients with chronic kidney disease (CKD) to improve care and monitor health. Studies show that virtual care can help manage CKD effectively, with no emergency dialysis needed and similar survival rates to traditional care. Additionally, patients reported high satisfaction and found virtual care helpful, especially during the COVID-19 pandemic.46789

How is the Virtual Care treatment for acute kidney injury different from other treatments?

Virtual Care for acute kidney injury is unique because it uses telemedicine and remote monitoring to provide care at home, which can help avoid emergency interventions like dialysis by ensuring continuous and effective monitoring of the patient's condition.14101112

What is the purpose of this trial?

Method: Randomized Controlled Trial Study Duration: 3 Years Study Centre(s) University of Calgary and University of Alberta Objectives: To fill care gaps by implementing strategies to reduce length of hospital stay, readmission rates, and improve long-term outcomes after Acute Kidney Injury (AKI). Number of Participants: Three Hundred and fifty four (n=354) Diagnosis and Main Inclusion Criteria: Hospitalized adults with AKI at high risk of hospital readmission or deathStudy Intervention: Multi-component Digital Health Solutions, including:1. Computerized Clinical Decision Support (CDS) and2. Virtual Care Delivered through Hospital at Home (VC) Duration of administration: Determined by the Patient's clinical team Reference therapy: Usual Care Statistical Analyses: Descriptive Analysis, Regression

Research Team

MJ

Matthew James, MD

Principal Investigator

University of Calgary

Eligibility Criteria

This trial is for hospitalized adults with Acute Kidney Injury (AKI) who are at high risk of being readmitted to the hospital or dying. The study aims to help these individuals by using virtual care strategies.

Inclusion Criteria

My LACE score is 12 or higher.
AKI identified in hospital using Kidney Disease Improving Global Outcomes (KDIGO) criteria
Meets all inclusion criteria of Virtual Home Hospital programs of Calgary and Edmonton zones
See 1 more

Exclusion Criteria

Non-Alberta residents
Resides outside the catchment areas for the Calgary and Edmonton Virtual Home Hospital programs
My care goals are focused on curing my illness or extending my life.
See 4 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Vanguard Phase

Initial implementation to establish feasibility and acceptability of the intervention

Varies

Treatment

Participants receive virtual care through Virtual Home Hospital programs, including digital remote patient monitoring and regular virtual assessments

Up to 45 days
Regular virtual assessments via telephone or videoconferencing

Follow-up

Participants are monitored for safety and effectiveness after treatment, including assessments of kidney function and complications of AKI

Up to 90 days

Treatment Details

Interventions

  • Virtual Care
Trial Overview The UPTAKE trial is testing a virtual home hospital system with remote monitoring against usual care for AKI patients. It's a randomized controlled trial, meaning people are put into groups by chance, and it will last three years.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Virtual CareExperimental Treatment1 Intervention
Participants will receive virtual care through Virtual Home Hospital programs in Alberta for their hospital to home transition of care.
Group II: Usual CareActive Control1 Intervention
Participants will be discharged as per usual care practices from hospital to their home.

Virtual Care is already approved in Canada for the following indications:

🇨🇦
Approved in Canada as Virtual Care for:
  • Acute Kidney Injury (AKI)
  • Reducing hospital readmission rates
  • Improving long-term outcomes

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Calgary

Lead Sponsor

Trials
827
Recruited
902,000+

Alberta Health services

Collaborator

Trials
168
Recruited
658,000+

Findings from Research

Participation in the Cricket Health program significantly improved CKD knowledge among patients, with scores increasing from an average of 52% to 94% correct answers on a knowledge-based survey.
Patients in the program were more likely to start dialysis in an outpatient setting (80% of those who started dialysis) compared to controls (22%), suggesting the program may facilitate better planning for dialysis initiation.
A Virtual Multidisciplinary Care Program for Management of Advanced Chronic Kidney Disease: Matched Cohort Study.Kaiser, P., Pipitone, O., Franklin, A., et al.[2020]
Telemedicine enabled effective management of a severely ill patient with sepsis and multi-organ failure, allowing for direct review and collaborative support without the need for risky long-distance transfer.
This approach maintained high healthcare standards and kept the patient close to their home and family, highlighting the potential of telemedicine in critical care situations.
The tyranny of distance: telemedicine for the critically ill in rural Australia.Boots, RJ., Singh, SJ., Lipman, J.[2019]
In a study of 64 patients using live interactive telenephrology, 31.2% had their treatment plans changed compared to what their referring health provider suggested, indicating effective diagnosis and management of kidney diseases.
Patients reported significant improvements in their quality of life, with SF8 scores increasing from 33.1 to 45.0 after 2 months, alongside high satisfaction rates due to reduced waiting times and costs associated with teleconsultations.
Telenephrology application in rural and remote areas of Jordan: benefits and impact on quality of life.AlAzab, R., Khader, Y.[2016]

References

A Virtual Multidisciplinary Care Program for Management of Advanced Chronic Kidney Disease: Matched Cohort Study. [2020]
The tyranny of distance: telemedicine for the critically ill in rural Australia. [2019]
Telenephrology application in rural and remote areas of Jordan: benefits and impact on quality of life. [2016]
A virtual clinic to improve long-term outcomes in chronic kidney disease. [2020]
Remote Patient Management in Peritoneal Dialysis Improves Clinical Outcomes. [2021]
Telemedicine to Promote Patient Safety: Use of Phone-Based Interactive Voice-Response System to Reduce Adverse Safety Events in Pre-dialysis CKD. [2022]
Usability of a CKD educational website targeted to patients and their family members. [2021]
Bridging "Office-Based Care" With the "Virtual Practice Care Model": Evolving Care for Chronic Kidney Disease Patients in the COVID-19 Pandemic-And Beyond. [2020]
Automated, electronic alerts for acute kidney injury: a single-blind, parallel-group, randomised controlled trial. [2023]
[The use of telemedicine in dialysis and new professional practices]. [2017]
Post-discharge after surgery Virtual Care with Remote Automated Monitoring-1 (PVC-RAM-1) technology versus standard care: randomised controlled trial. [2021]
A Quantitative and Qualitative Study on Patient and Physician Perceptions of Nephrology Telephone Consultation During COVID-19. [2022]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security